M. Østergaard

发表

Gain in Quality-adjusted Life-years in Patients with Rheumatoid Arthritis During 1 Year of Biological Therapy: A Prospective Study in Clinical Practice

M. Østergaard, J. Sørensen, M. Hetland, 2013, The Journal of Rheumatology.

Impact of Nonpharmacologic Interventions Targeting Sleep Disturbances or Disorders in Patients With Inflammatory Arthritis: A Systematic Review and Meta‐Analysis of Randomized Trials

K. Løppenthin, K. M. Latocha, B. Esbensen, 2022 .

Impact of Nonpharmacologic Interventions Targeting Sleep Disturbances or Disorders in Patients With Inflammatory Arthritis A systematic review and meta-analysis of randomized trials

P. Jennum, K. Løppenthin, K. M. Latocha, 2021 .

Detection of rheumatoid arthritis bone erosions by two different dedicated extremity MRI units and conventional radiography

M. Østergaard, B. Ejbjerg, M. Hetland, 2007, Annals of the rheumatic diseases.

Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab—a substudy of the optimized treatment algorithm in early RA (OPERA) trial

H. Bliddal, K. Stengaard-Pedersen, H. C. Horn, 2017, Clinical Rheumatology.

Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis

H. Idborg, B. Gudbjornsson, G. Gröndal, 2024, Arthritis research & therapy.

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.

D. D. Giuseppe, B. Gudbjornsson, F. Iannone, 2024, Seminars in Arthritis & Rheumatism.

Development and Validation of an OMERACT MRI Whole-Body Score for Inflammation in Peripheral Joints and Entheses in Inflammatory Arthritis (MRI-WIPE)

J. Jaremko, C. Peterfy, P. Conaghan, 2019, The Journal of Rheumatology.

Occurrence and Prediction of Flare After Tapering of Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis

H. Røgind, M. Hetland, K. Gosvig, 2023, The Journal of Rheumatology.

Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care

B. Gudbjornsson, T. Love, F. Iannone, 2024, The Journal of Rheumatology.

Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study

S. Zhao, M. Kapetanovic, B. Gudbjornsson, 2024, RMD open.

Syddansk Universitet Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial protocol for a cohort study with patient-record evaluated outcomes

P. Vestergaard, R. Christensen, M. Østergaard, 2017 .

Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes

T. Ellingsen, J. Pødenphant, K. Hørslev-Petersen, 2017, BMJ Open.

AB0244 Development of an adjusted multi-biomarker disease activity (MBDA) score for rheumatoid arthritis (RA) that accounts for age, sex and adiposity, with subsequent evaluation of ability to predict risk for radiographic damage

A. Gutin, M. Weinblatt, N. Shadick, 2018, Rheumatoid arthritis – prognosis, predictors and outcome.

Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study

A. Rudin, M. Østergaard, T. Uhlig, 2017, Trials.

Plasma YKL‐40: a potential biomarker for psoriatic arthritis?

L. Skov, J. Johansen, M. Østergaard, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.